In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children: a multisite, open-label, two-cohort, clinical trial in Mozambique

BACKGROUND: Mozambique adopted artemisinin-based combination therapy (ACT) for the treatment of uncomplicated Plasmodium falciparum malaria in the year 2006, and since 2009 artemether-lumefantrine (AL) and artesunate-amodiaquine (ASAQ) have been proposed as alternative first-line treatments. A multi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nhama, Abel, Bassat, Quique, Enosse, Sónia, Nhacolo, Arsenio, Mutemba, Rosália, Carvalho, Eva, Naueia, Eva, Sevene, Esperança, Guinovart, Caterina, Warsame, Marian, Sanz, Sergi, Mussa, Abdul, Matsinhe, Graça, Alonso, Pedro, Tiago, Armindo, Macete, Eusebio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132202/
https://www.ncbi.nlm.nih.gov/pubmed/25108397
http://dx.doi.org/10.1186/1475-2875-13-309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132202/
https://www.ncbi.nlm.nih.gov/pubmed/25108397
http://dx.doi.org/10.1186/1475-2875-13-309

Ejemplares similares